aluates Reports

$ 0.0

Automative

Global CRO in Clinical Trials Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-11M5974

Global CRO in Clinical Trials Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global CRO in Clinical Trials Market Research Report 2025

Code: QYRE-Auto-11M5974

Report

March 2025

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Syneos Health

PAREXEL

PRA Health Sciences

PPD

ICON

WuXi AppTec

LabCorp

IQVIA

Medpace Holdings

Tigermed

Boji Medical Technology

Pharmaron

CRO in Clinical Trials Market Size

The global market for CRO in Clinical Trials was valued at US$ 51240 million in the year 2024 and is projected to reach a revised size of US$ 95760 million by 2031, growing at a CAGR of 9.5% during the forecast period.

CRO in Clinical Trials Market

A CRO (Contract Research Organization) is a company that provides clinical trial management services for the pharmaceutical, biotech, and medical device industries. Although there are different types of CROs and diverse levels of specialization (distinct therapeutic areas for instance), typical CRO services include regulatory affairs, site selection and activation, recruitment support, clinical monitoring, data management, trial logistics, pharmacovigilance, biostatistics, medical writing, and project management, among others. In a clinical trial, CROs are hired by sponsors to perform a set of tasks, taking various technical and administrative responsibilities on the sponsor’s behalf. The main role of the CRO is to plan, coordinate, execute, and supervise the processes involved in the development of a clinical trial, being a central contact point between the sponsor and other trial actors (e.g. ethics committees, regulatory agencies, vendors, and hospitals).

Global core CRO in clinical trials players include Labcorp, IQVIA and Parexel etc. The top 5 companies hold a share about 40%. North America is the largest market, with a share about 45%, followed by Europe and Asia Pacific with the share about 35% and 20%. In terms of product, phase iii trial is the largest segment, with a share about 35%. And in terms ofend users, the largest end user is pharmaceutical，with a share about 55%.

The market for Contract Research Organizations (CROs) in clinical trials is experiencing significant growth and evolution due to various factors:

Biopharmaceutical Companies: Many pharma and biotech firms are increasingly outsourcing clinical trials to CROs to reduce costs, improve efficiency, and tap into specialized expertise. This trend is particularly notable among smaller biotech companies with limited infrastructure.

Focus on Core Competencies: Large pharmaceutical companies prefer focusing on core R&D activities, delegating clinical trial processes to CROs for scalability and cost-effectiveness.

Decentralized Clinical Trials (DCTs): CROs are innovating with decentralized trial models, enabling remote patient monitoring and data collection. This trend has accelerated post-COVID-19, enhancing patient recruitment, retention, and trial accessibility.

Adaptive and Hybrid Trials: The need for quicker, adaptable trials that can respond to real-time data is driving hybrid and adaptive trial designs. CROs are investing in capabilities to support these complex trial models.

Expanding Trials in APAC and LATAM: CROs are increasingly establishing operations in Asia-Pacific, Latin America, and Eastern Europe, where costs are lower, and recruitment pools are larger.

Regulatory Alignment: Many countries are harmonizing their regulatory requirements with global standards, making it easier for CROs to conduct trials internationally.

Artificial Intelligence (AI) and Machine Learning (ML): CROs are adopting AI/ML for predictive modeling, patient recruitment, trial monitoring, and data analysis, increasing accuracy and efficiency.

Digital Health Technologies: Wearable devices and digital health tools for real-time data capture are becoming integral in trials, supporting both remote and hybrid trial models.

Specialized Trials: Growth in oncology and rare disease research, which often require specialized trial designs and complex patient recruitment, is pushing CROs to develop niche expertise.

Patient-Centric Approaches: CROs are focusing on patient-centric methods to enhance participation and retention, especially in studies with rare or hard-to-reach patient populations.

Compliance and Quality Control: As regulations become more stringent, CROs are enhancing their quality assurance programs to ensure compliance with Good Clinical Practice (GCP) and international standards.

Data Security and Privacy: CROs are also adapting to increased demands for data privacy, especially with the rise in remote and decentralized trials.

This report aims to provide a comprehensive presentation of the global market for CRO in Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRO in Clinical Trials.

The CRO in Clinical Trials market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CRO in Clinical Trials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the CRO in Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of CRO in Clinical Trials Market Report

Report Metric	Details
Report Name	CRO in Clinical Trials Market
Accounted market size in year	US$ 51240 million
Forecasted market size in 2031	US$ 95760 million
CAGR	9.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Phase I Trial Phase II Trial Phase III Trial Phase IV Trial
Segment by Application	Pharmaceutical Bio-pharm Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Labcorp, IQVIA, Parexel, Syneos Health, PRA Health Sciences, PPD, ICON, Medpace Holdings, Wuxi Apptec, Tigermed, Boji Medical Technology, Pharmaron
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRO in Clinical Trials company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is CRO in Clinical Trials Market growing?

Ans: The CRO in Clinical Trials Market witnessing a CAGR of 9.5% during the forecast period 2025-2031.

What is the CRO in Clinical Trials Market size in 2031?

Ans: The CRO in Clinical Trials Market size in 2031 will be US$ 95760 million.

What is the market share of major companies in CRO in Clinical Trials Market?

Ans: The top 5 companies hold a share about 40%.

What is the CRO in Clinical Trials Market share by region?

Ans: North America is the largest market, with a share about 45%, followed by Europe and Asia Pacific with the share about 35% and 20%.

What is the CRO in Clinical Trials Market share by type?

Ans: In terms of product, phase iii trial is the largest segment, with a share about 35%.

Who are the main players in the CRO in Clinical Trials Market report?

Ans: The main players in the CRO in Clinical Trials Market are Labcorp, IQVIA, Parexel, Syneos Health, PRA Health Sciences, PPD, ICON, Medpace Holdings, Wuxi Apptec, Tigermed, Boji Medical Technology, Pharmaron

What are the Application segmentation covered in the CRO in Clinical Trials Market report?

Ans: The Applications covered in the CRO in Clinical Trials Market report are Pharmaceutical, Bio-pharm, Others

What are the Type segmentation covered in the CRO in Clinical Trials Market report?

Ans: The Types covered in the CRO in Clinical Trials Market report are Phase I Trial, Phase II Trial, Phase III Trial, Phase IV Trial

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global CRO in Clinical Trials Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Phase I Trial

1.2.3 Phase II Trial

1.2.4 Phase III Trial

1.2.5 Phase IV Trial

1.3 Market by Application

1.3.1 Global CRO in Clinical Trials Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical

1.3.3 Bio-pharm

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global CRO in Clinical Trials Market Perspective (2020-2031)

2.2 Global CRO in Clinical Trials Growth Trends by Region

2.2.1 Global CRO in Clinical Trials Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 CRO in Clinical Trials Historic Market Size by Region (2020-2025)

2.2.3 CRO in Clinical Trials Forecasted Market Size by Region (2026-2031)

2.3 CRO in Clinical Trials Market Dynamics

2.3.1 CRO in Clinical Trials Industry Trends

2.3.2 CRO in Clinical Trials Market Drivers

2.3.3 CRO in Clinical Trials Market Challenges

2.3.4 CRO in Clinical Trials Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top CRO in Clinical Trials Players by Revenue

3.1.1 Global Top CRO in Clinical Trials Players by Revenue (2020-2025)

3.1.2 Global CRO in Clinical Trials Revenue Market Share by Players (2020-2025)

3.2 Global CRO in Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by CRO in Clinical Trials Revenue

3.4 Global CRO in Clinical Trials Market Concentration Ratio

3.4.1 Global CRO in Clinical Trials Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by CRO in Clinical Trials Revenue in 2024

3.5 Global Key Players of CRO in Clinical Trials Head office and Area Served

3.6 Global Key Players of CRO in Clinical Trials, Product and Application

3.7 Global Key Players of CRO in Clinical Trials, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 CRO in Clinical Trials Breakdown Data by Type

4.1 Global CRO in Clinical Trials Historic Market Size by Type (2020-2025)

4.2 Global CRO in Clinical Trials Forecasted Market Size by Type (2026-2031)

5 CRO in Clinical Trials Breakdown Data by Application

5.1 Global CRO in Clinical Trials Historic Market Size by Application (2020-2025)

5.2 Global CRO in Clinical Trials Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America CRO in Clinical Trials Market Size (2020-2031)

6.2 North America CRO in Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America CRO in Clinical Trials Market Size by Country (2020-2025)

6.4 North America CRO in Clinical Trials Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe CRO in Clinical Trials Market Size (2020-2031)

7.2 Europe CRO in Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe CRO in Clinical Trials Market Size by Country (2020-2025)

7.4 Europe CRO in Clinical Trials Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific CRO in Clinical Trials Market Size (2020-2031)

8.2 Asia-Pacific CRO in Clinical Trials Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific CRO in Clinical Trials Market Size by Region (2020-2025)

8.4 Asia-Pacific CRO in Clinical Trials Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America CRO in Clinical Trials Market Size (2020-2031)

9.2 Latin America CRO in Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America CRO in Clinical Trials Market Size by Country (2020-2025)

9.4 Latin America CRO in Clinical Trials Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa CRO in Clinical Trials Market Size (2020-2031)

10.2 Middle East & Africa CRO in Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa CRO in Clinical Trials Market Size by Country (2020-2025)

10.4 Middle East & Africa CRO in Clinical Trials Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Labcorp

11.1.1 Labcorp Company Details

11.1.2 Labcorp Business Overview

11.1.3 Labcorp CRO in Clinical Trials Introduction

11.1.4 Labcorp Revenue in CRO in Clinical Trials Business (2020-2025)

11.1.5 Labcorp Recent Development

11.2 IQVIA

11.2.1 IQVIA Company Details

11.2.2 IQVIA Business Overview

11.2.3 IQVIA CRO in Clinical Trials Introduction

11.2.4 IQVIA Revenue in CRO in Clinical Trials Business (2020-2025)

11.2.5 IQVIA Recent Development

11.3 Parexel

11.3.1 Parexel Company Details

11.3.2 Parexel Business Overview

11.3.3 Parexel CRO in Clinical Trials Introduction

11.3.4 Parexel Revenue in CRO in Clinical Trials Business (2020-2025)

11.3.5 Parexel Recent Development

11.4 Syneos Health

11.4.1 Syneos Health Company Details

11.4.2 Syneos Health Business Overview

11.4.3 Syneos Health CRO in Clinical Trials Introduction

11.4.4 Syneos Health Revenue in CRO in Clinical Trials Business (2020-2025)

11.4.5 Syneos Health Recent Development

11.5 PRA Health Sciences

11.5.1 PRA Health Sciences Company Details

11.5.2 PRA Health Sciences Business Overview

11.5.3 PRA Health Sciences CRO in Clinical Trials Introduction

11.5.4 PRA Health Sciences Revenue in CRO in Clinical Trials Business (2020-2025)

11.5.5 PRA Health Sciences Recent Development

11.6 PPD

11.6.1 PPD Company Details

11.6.2 PPD Business Overview

11.6.3 PPD CRO in Clinical Trials Introduction

11.6.4 PPD Revenue in CRO in Clinical Trials Business (2020-2025)

11.6.5 PPD Recent Development

11.7 ICON

11.7.1 ICON Company Details

11.7.2 ICON Business Overview

11.7.3 ICON CRO in Clinical Trials Introduction

11.7.4 ICON Revenue in CRO in Clinical Trials Business (2020-2025)

11.7.5 ICON Recent Development

11.8 Medpace Holdings

11.8.1 Medpace Holdings Company Details

11.8.2 Medpace Holdings Business Overview

11.8.3 Medpace Holdings CRO in Clinical Trials Introduction

11.8.4 Medpace Holdings Revenue in CRO in Clinical Trials Business (2020-2025)

11.8.5 Medpace Holdings Recent Development

11.9 Wuxi Apptec

11.9.1 Wuxi Apptec Company Details

11.9.2 Wuxi Apptec Business Overview

11.9.3 Wuxi Apptec CRO in Clinical Trials Introduction

11.9.4 Wuxi Apptec Revenue in CRO in Clinical Trials Business (2020-2025)

11.9.5 Wuxi Apptec Recent Development

11.10 Tigermed

11.10.1 Tigermed Company Details

11.10.2 Tigermed Business Overview

11.10.3 Tigermed CRO in Clinical Trials Introduction

11.10.4 Tigermed Revenue in CRO in Clinical Trials Business (2020-2025)

11.10.5 Tigermed Recent Development

11.11 Boji Medical Technology

11.11.1 Boji Medical Technology Company Details

11.11.2 Boji Medical Technology Business Overview

11.11.3 Boji Medical Technology CRO in Clinical Trials Introduction

11.11.4 Boji Medical Technology Revenue in CRO in Clinical Trials Business (2020-2025)

11.11.5 Boji Medical Technology Recent Development

11.12 Pharmaron

11.12.1 Pharmaron Company Details

11.12.2 Pharmaron Business Overview

11.12.3 Pharmaron CRO in Clinical Trials Introduction

11.12.4 Pharmaron Revenue in CRO in Clinical Trials Business (2020-2025)

11.12.5 Pharmaron Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Syneos Health

PAREXEL

PRA Health Sciences

PPD

ICON

WuXi AppTec

LabCorp

IQVIA

Medpace Holdings

Tigermed

Boji Medical Technology

Pharmaron

List of Tables

Table 1. Global CRO in Clinical Trials Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Phase I Trial

Table 3. Key Players of Phase II Trial

Table 4. Key Players of Phase III Trial

Table 5. Key Players of Phase IV Trial

Table 6. Global CRO in Clinical Trials Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global CRO in Clinical Trials Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global CRO in Clinical Trials Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global CRO in Clinical Trials Market Share by Region (2020-2025)

Table 10. Global CRO in Clinical Trials Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global CRO in Clinical Trials Market Share by Region (2026-2031)

Table 12. CRO in Clinical Trials Market Trends

Table 13. CRO in Clinical Trials Market Drivers

Table 14. CRO in Clinical Trials Market Challenges

Table 15. CRO in Clinical Trials Market Restraints

Table 16. Global CRO in Clinical Trials Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global CRO in Clinical Trials Market Share by Players (2020-2025)

Table 18. Global Top CRO in Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRO in Clinical Trials as of 2024)

Table 19. Ranking of Global Top CRO in Clinical Trials Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by CRO in Clinical Trials Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of CRO in Clinical Trials, Headquarters and Area Served

Table 22. Global Key Players of CRO in Clinical Trials, Product and Application

Table 23. Global Key Players of CRO in Clinical Trials, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global CRO in Clinical Trials Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global CRO in Clinical Trials Revenue Market Share by Type (2020-2025)

Table 27. Global CRO in Clinical Trials Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global CRO in Clinical Trials Revenue Market Share by Type (2026-2031)

Table 29. Global CRO in Clinical Trials Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global CRO in Clinical Trials Revenue Market Share by Application (2020-2025)

Table 31. Global CRO in Clinical Trials Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global CRO in Clinical Trials Revenue Market Share by Application (2026-2031)

Table 33. North America CRO in Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America CRO in Clinical Trials Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America CRO in Clinical Trials Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe CRO in Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe CRO in Clinical Trials Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe CRO in Clinical Trials Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific CRO in Clinical Trials Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific CRO in Clinical Trials Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific CRO in Clinical Trials Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America CRO in Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America CRO in Clinical Trials Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America CRO in Clinical Trials Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa CRO in Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa CRO in Clinical Trials Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa CRO in Clinical Trials Market Size by Country (2026-2031) & (US$ Million)

Table 48. Labcorp Company Details

Table 49. Labcorp Business Overview

Table 50. Labcorp CRO in Clinical Trials Product

Table 51. Labcorp Revenue in CRO in Clinical Trials Business (2020-2025) & (US$ Million)

Table 52. Labcorp Recent Development

Table 53. IQVIA Company Details

Table 54. IQVIA Business Overview

Table 55. IQVIA CRO in Clinical Trials Product

Table 56. IQVIA Revenue in CRO in Clinical Trials Business (2020-2025) & (US$ Million)

Table 57. IQVIA Recent Development

Table 58. Parexel Company Details

Table 59. Parexel Business Overview

Table 60. Parexel CRO in Clinical Trials Product

Table 61. Parexel Revenue in CRO in Clinical Trials Business (2020-2025) & (US$ Million)

Table 62. Parexel Recent Development

Table 63. Syneos Health Company Details

Table 64. Syneos Health Business Overview

Table 65. Syneos Health CRO in Clinical Trials Product

Table 66. Syneos Health Revenue in CRO in Clinical Trials Business (2020-2025) & (US$ Million)

Table 67. Syneos Health Recent Development

Table 68. PRA Health Sciences Company Details

Table 69. PRA Health Sciences Business Overview

Table 70. PRA Health Sciences CRO in Clinical Trials Product

Table 71. PRA Health Sciences Revenue in CRO in Clinical Trials Business (2020-2025) & (US$ Million)

Table 72. PRA Health Sciences Recent Development

Table 73. PPD Company Details

Table 74. PPD Business Overview

Table 75. PPD CRO in Clinical Trials Product

Table 76. PPD Revenue in CRO in Clinical Trials Business (2020-2025) & (US$ Million)

Table 77. PPD Recent Development

Table 78. ICON Company Details

Table 79. ICON Business Overview

Table 80. ICON CRO in Clinical Trials Product

Table 81. ICON Revenue in CRO in Clinical Trials Business (2020-2025) & (US$ Million)

Table 82. ICON Recent Development

Table 83. Medpace Holdings Company Details

Table 84. Medpace Holdings Business Overview

Table 85. Medpace Holdings CRO in Clinical Trials Product

Table 86. Medpace Holdings Revenue in CRO in Clinical Trials Business (2020-2025) & (US$ Million)

Table 87. Medpace Holdings Recent Development

Table 88. Wuxi Apptec Company Details

Table 89. Wuxi Apptec Business Overview

Table 90. Wuxi Apptec CRO in Clinical Trials Product

Table 91. Wuxi Apptec Revenue in CRO in Clinical Trials Business (2020-2025) & (US$ Million)

Table 92. Wuxi Apptec Recent Development

Table 93. Tigermed Company Details

Table 94. Tigermed Business Overview

Table 95. Tigermed CRO in Clinical Trials Product

Table 96. Tigermed Revenue in CRO in Clinical Trials Business (2020-2025) & (US$ Million)

Table 97. Tigermed Recent Development

Table 98. Boji Medical Technology Company Details

Table 99. Boji Medical Technology Business Overview

Table 100. Boji Medical Technology CRO in Clinical Trials Product

Table 101. Boji Medical Technology Revenue in CRO in Clinical Trials Business (2020-2025) & (US$ Million)

Table 102. Boji Medical Technology Recent Development

Table 103. Pharmaron Company Details

Table 104. Pharmaron Business Overview

Table 105. Pharmaron CRO in Clinical Trials Product

Table 106. Pharmaron Revenue in CRO in Clinical Trials Business (2020-2025) & (US$ Million)

Table 107. Pharmaron Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. CRO in Clinical Trials Picture

Figure 2. Global CRO in Clinical Trials Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global CRO in Clinical Trials Market Share by Type: 2024 VS 2031

Figure 4. Phase I Trial Features

Figure 5. Phase II Trial Features

Figure 6. Phase III Trial Features

Figure 7. Phase IV Trial Features

Figure 8. Global CRO in Clinical Trials Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global CRO in Clinical Trials Market Share by Application: 2024 VS 2031

Figure 10. Pharmaceutical Case Studies

Figure 11. Bio-pharm Case Studies

Figure 12. Others Case Studies

Figure 13. CRO in Clinical Trials Report Years Considered

Figure 14. Global CRO in Clinical Trials Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global CRO in Clinical Trials Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global CRO in Clinical Trials Market Share by Region: 2024 VS 2031

Figure 17. Global CRO in Clinical Trials Market Share by Players in 2024

Figure 18. Global Top CRO in Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRO in Clinical Trials as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by CRO in Clinical Trials Revenue in 2024

Figure 20. North America CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America CRO in Clinical Trials Market Share by Country (2020-2031)

Figure 22. United States CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe CRO in Clinical Trials Market Share by Country (2020-2031)

Figure 26. Germany CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific CRO in Clinical Trials Market Share by Region (2020-2031)

Figure 34. China CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America CRO in Clinical Trials Market Share by Country (2020-2031)

Figure 42. Mexico CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa CRO in Clinical Trials Market Share by Country (2020-2031)

Figure 46. Turkey CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE CRO in Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Labcorp Revenue Growth Rate in CRO in Clinical Trials Business (2020-2025)

Figure 50. IQVIA Revenue Growth Rate in CRO in Clinical Trials Business (2020-2025)

Figure 51. Parexel Revenue Growth Rate in CRO in Clinical Trials Business (2020-2025)

Figure 52. Syneos Health Revenue Growth Rate in CRO in Clinical Trials Business (2020-2025)

Figure 53. PRA Health Sciences Revenue Growth Rate in CRO in Clinical Trials Business (2020-2025)

Figure 54. PPD Revenue Growth Rate in CRO in Clinical Trials Business (2020-2025)

Figure 55. ICON Revenue Growth Rate in CRO in Clinical Trials Business (2020-2025)

Figure 56. Medpace Holdings Revenue Growth Rate in CRO in Clinical Trials Business (2020-2025)

Figure 57. Wuxi Apptec Revenue Growth Rate in CRO in Clinical Trials Business (2020-2025)

Figure 58. Tigermed Revenue Growth Rate in CRO in Clinical Trials Business (2020-2025)

Figure 59. Boji Medical Technology Revenue Growth Rate in CRO in Clinical Trials Business (2020-2025)

Figure 60. Pharmaron Revenue Growth Rate in CRO in Clinical Trials Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Clinical Contract Research Organization Services Market Research Report 2024

Global Contract Research Organisations CROs Market Research Report 2024

Clinical CRO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Contract Research Organization Solution Market Research Report 2025

Healthcare Contract Research Organizations CRO Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Healthcare Contract Research Organization Market Insights Forecast to 2030

Contract Research Organizations Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

CROs Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Clinical and Non clinical Contract Research Organization Services Market Research Report 2024

Global Clinical CRO Laboratory Services Market Research Report 2024

Global Pharmaceutical CRO Services Market Research Report 2024

Global Full Service CRO Market Research Report 2024

Global Contract Research Organization CRO Services Market Insights Forecast to 2030

Global CRO Services for BioPharma Market Research Report 2024

Global The Contract Research CRO Market Insights Forecast to 2030

Global Full Service Clinical Research Organization CRO Market Research Report 2025

Global Preclinical Contract Research Organization CRO Market Research Report 2025

Global Healthcare CRO Market Insights Forecast to 2030

Clinical Research Organization Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions